195 1 production of tincture aqua
Start production of 196 1 insect repellent piperazine.
1962 is the first company in China to start producing saponin, an important precursor of chemical synthesis, which opened the era of chemical raw material production in China.
1965 the first domestic company to start producing CA&; Sup2 antagonist can be determined and won the title of municipal quality product for many times.
1969 began to produce hormone product-methyltestosterone; Maitong Soft Capsule, the first domestic soft capsule manufacturer, was put into production.
1970 began to produce oral contraceptives-norethindrone.
1972 started to produce hydrocortisone.
Production of cimetidine with 1980
198 1 started to produce verapamil.
198 1 The first domestic soft capsule manufacturer invested in Maishun soft capsules.
1982 is the first ambroxol manufacturer in China.
1985 is the first domestic producer of norfloxacin; The first company in China to produce four new drugs-Gan 'angan syrup.
1989 nimodipine was produced for the first time in China.
The national eighth five-year plan project ciprofloxacin began production.
1994 three kinds of Shuangqing mixture of traditional Chinese medicine were put into production.
1995 took the lead in realizing the industrialization of "solid dispersion technology" in China and solved the technical problem of low bioavailability of nimodipine tablets; The product is officially listed in Nidal.
1996 domestic second-class new drug Gao Pei pu zhong su; Product proliferation plain film, a key project of the national five-year plan.
1997 invested in a new Chinese medicine preparation, Maren Soft Capsule Methadone Hydrochloride Oral Liquid, and obtained the production approval (national fourth-class new drug).
1998 methadone hydrochloride tablets were approved for production.
1999 Multi-dimensional Effervescent Tablets, Guanxin Suhe Soft Capsules (the fourth new drug in China) and amino acid granules (14) were approved for production.
In 2000, moxonidine hydrochloride and its tablets (national second-class new drugs), phentolamine mesylate, royal jelly capsules, Shuang Fu soft capsules and Tianqi soft capsules were approved for production.
200 1 cefdinir and its capsules, Maxing Shigan soft capsules and cefaclor sustained-release tablets were approved for production.
In 2002, China exclusively produced four kinds of national new drugs, namely, cefdinir bulk drug, Shifeni (cefdinir capsule) and Cephalosporin intermediate GCLE.
In 2004, methadone hydrochloride resumed fixed-point production.